王冰琼,单姗,孔媛媛,吴晓宁,周家玲,孙亚朦,陈姝延,王皓,徐小倩,夏帅,贾继东,尤红,中国消除乙肝临床研究平台(CR-HepB)研究组. 世界卫生组织2024年版乙型肝炎防治指南与中国指南抗病毒治疗覆盖人群的比较 [J] . 中华肝脏病杂志, ...
6. Terrault NA, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance[J]. Hepatology (Baltimore, Md), 2018, 67(4): 1560-1599. DOI: 10.1002/hep.29800.7. European Association for the Study of the Liver. EASL 2017 Clinical ...
17. Choi HSJ, Brouwer WP, Zanjir WMR, de Man RA, Feld JJ, Hansen B et al. Nonalcoholic steatohepatitis is associated with liver-related outcomes and all-cause mortality in chronic hepatitis B. Hepatology. 2020;71:539–48. doi: 10.1002/hep.30857. 18. Kim MA, Han K, Yoo J, Hwang S...
17. Choi HSJ, Brouwer WP, Zanjir WMR, de Man RA, Feld JJ, Hansen B et al. Nonalcoholic steatohepatitis is associated with liver-related outcomes and all-cause mortality in chronic hepatitis B. Hepatology. 2020;71:539–48. doi: 10.1002/hep.30857. 18. Kim MA, Han K, Yoo J, Hwang S...
6. Terrault NA, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance[J]. Hepatology (Baltimore, Md), 2018, 67(4): 1560-1599. DOI: 10.1002/hep.29800. 7. European Association for the Study of the Liver. EASL 2017 Clinical Practi...
6. Terrault NA, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance[J]. Hepatology (Baltimore, Md), 2018, 67(4): 1560-1599. DOI: 10.1002/hep.29800. 7. European Association for the Study of the Liver. EASL 2017 Clinical Practi...
6. Terrault NA, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance[J]. Hepatology (Baltimore, Md), 2018, 67(4): 1560-1599. DOI: 10.1002/hep.29800. 7....
研究共纳入150例CHD患者,随机分成了3个治疗组,分别是延迟治疗的A组(前48周不进行抗病毒治疗,之后接受96周的10 mg BLV治疗,n=51)、接受144周2 mg BLV治疗的B组(n=49),以及接受144周10 mg BLV治疗的C组(n=50)。BLV治疗方式为每天一次,皮下注射。三组患者完成治疗后均将接受为期96周的停药随访。
doi:10.1016/j.aohep.2019.03.001Octavio Campollo a bSonia Roman bAnnals of Hepatology
17. Choi HSJ, Brouwer WP, Zanjir WMR, de Man RA, Feld JJ, Hansen B et al. Nonalcoholic steatohepatitis is associated with liver-related outcomes and all-cause mortality in chronic hepatitis B. Hepatology. 2020;71:539–...